Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 15, 2020, Jeffrey D. Capello ceased to be the Executive Vice President and Chief Financial Officer of Biogen Inc. (the "Company") and ceased to be employed by the Company effective September 15, 2020. In connection with Mr. Capello's departure, he will receive the severance benefits required under the Company's executive severance policy for Executive Vice Presidents. In addition, in recognition of Mr. Capello's contributions to the Company, the Compensation and Management Development Committee of the Board of Directors waived the requirement that Mr. Capello be required to repay 35% of his original cash sign-on bonus and approved a cash payment to him of $2.6 million. Item 9.01 Financial Statements and Exhibits.



(d) Exhibits
Exhibit No.              Description
                         Cover Page Interactive Data File (embedded within the Inline XBRL
104                      document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses